126 related articles for article (PubMed ID: 28795954)
1. The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran.
Golmohammadi R; Baesi K; Moradi A; Farrokhi M; McFarland W; Parsamajd S
Intervirology; 2017; 60(1-2):33-37. PubMed ID: 28795954
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
[TBL] [Abstract][Full Text] [Related]
3. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
[TBL] [Abstract][Full Text] [Related]
5. Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naïve people in Kuwait.
Chehadeh W; Albaksami O; Altawalah H; Ahmad S; Madi N; John SE; Abraham PS; Al-Nakib W
J Med Virol; 2015 Sep; 87(9):1521-6. PubMed ID: 25976289
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of drug resistance mutations in the human immunodeficiency virus reverse transcriptase gene in patients who are non-responsive, responsive and naive to antiretroviral therapy.
Misbah M; Roy G; Shahid M; Nag N; Kumar S; Husain M
Arch Virol; 2016 May; 161(5):1101-13. PubMed ID: 26801790
[TBL] [Abstract][Full Text] [Related]
7. HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.
Farrokhi M; Moallemi S; Baesi K; Ahsani-Nasab S; Gholami M; Sadeghi L; Mohraz M
Intervirology; 2016; 59(3):131-136. PubMed ID: 27974715
[TBL] [Abstract][Full Text] [Related]
8. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.
Jahanbakhsh F; Hattori J; Matsuda M; Ibe S; Monavari SH; Memarnejadian A; Aghasadeghi MR; Mostafavi E; Mohraz M; Jabbari H; Kamali K; Keyvani H; Azadmanesh K; Sugiura W
PLoS One; 2013; 8(4):e61864. PubMed ID: 23626742
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
[TBL] [Abstract][Full Text] [Related]
12. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antiretroviral drug resistance among treatment-naive and treated HIV-infected individuals in Shiraz, Iran.
Davarpanah MA; Motazedian N; Joulaei H; Aghasadeghi MR; Faramarzi H; Aghah E
Arch Virol; 2018 Jan; 163(1):99-104. PubMed ID: 28986714
[TBL] [Abstract][Full Text] [Related]
14. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.
Bure D; Makhdoomi MA; Lodha R; Prakash SS; Kumar R; Parray HA; Singh R; Kabra SK; Luthra K
Viruses; 2015 Feb; 7(2):590-603. PubMed ID: 25674767
[TBL] [Abstract][Full Text] [Related]
17. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
19. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
Richard N; Juntilla M; Abraha A; Demers K; Paxinos E; Galovich J; Petropoulos C; Whalen CC; Kyeyune F; Atwine D; Kityo C; Mugyenyi P; Arts EJ
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):355-64. PubMed ID: 15157354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
